BULLISHWHALES
BullishWhales · Analysts · Analyst Profile

Samantha Semenkow

Citigroup · Equity Research Analyst

Analyst rating accuracy & track record

Samantha Semenkow does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
CABACabaletta Bio Inc
Buy$13.00May 2025+61.0%Miss
ALLOAllogene Therapeutics Inc
Buy$4.00May 2025+69.2%Hit
GPCRStructure Therapeutics Inc. American Depositary Shares
Buy$60.00May 2025+49.6%Hit
VYGRVoyager Therapeutics Inc
Buy$12.00Dec 2024−49.6%Miss
BIOABioAge Labs, Inc
Buy$45.00Oct 2024−75.4%Miss
SANASana Biotechnology Inc
Buy$15.00Aug 2024−29.0%Miss
CPRXCatalyst Pharmaceuticals Inc
Buy$31.00Aug 2024+13.3%Miss
SNSESensei Biotherapeutics Inc
Buy$4.00Jun 2024−42.9%Miss
LRMRLarimar Therapeutics Inc
Buy$14.00May 2024−65.7%Miss
CPRXCatalyst Pharmaceuticals Inc
Buy$27.00Mar 2024+29.5%Miss
SANASana Biotechnology Inc
Buy$8.00Sep 2023−28.2%Hit
SNSESensei Biotherapeutics Inc
Buy$6.00Dec 2022−58.5%Miss
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30